It uses electromagnetic waves to target tumors and is available to patients for whom first- and second-line treatments have ...
From detecting early disease to guiding treatment plans, clinicians are finding ctDNA testing increasingly important.
Ensartinib has received FDA approval for the first-line treatment of ALK-positive locally advanced or metastatic non–small ...
"According to the World Health Organization, about one third of cancers can be prevented through measures like proper ...
Liam Handley - who had suffered from anxiety for much of his life - went to his GP with chest pains, which his doctor put ...
News Medical on MSN19h
New drug approach shows promise in treating metabolic liver diseasesA MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver diseases. In an experimental ...
Medical Xpress on MSN13h
Promising therapeutic approach for metabolic liver diseasesA MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver diseases. In an experimental ...
Ensartinib has received FDA approval for the first-line treatment of anaplastic lymphoma kinase (ALK)-positive locally ...
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today announced five presentations featuring botensilimab (BOT, an Fc-enhanced anti-CTLA-4 antibody) plus balstilimab (BAL, an anti-PD-1 ...
Millions of people take metformin, a Type 2 diabetes medication that lowers blood sugar. The "wonder drug" has also been shown to slow cancer growth, improve COVID outcomes and reduce inflammation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback